Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention

American Heart Journal

Volumn 164, Issue 2, 2012, Pages 243-250

  Shaw, Leslee J ^a   Weintraub, William S ^b   Maron, David J ^c   Hartigan, Pamela M ^d   Hachamovitch, Rory ^e   Min, James K ^f   Dada, Marcin ^g   Mancini, G B John ^h   Hayes, Sean W ^f   O'Rourke, Robert A ⁱ   Spertus, John A ^j   Kostuk, William ^k   Gosselin, Gilbert ^l   Chaitman, Bernard R ^m   Knudtson, Merill ⁿ   Friedman, John ^f   Slomka, Piotr ^f   Germano, Guido ^f   Bates, Eric R ^o   Teo, Koon K ^p   Boden, William E ^q   Berman, Daniel S ^f   more..

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g HARTFORD HOSPITAL   (United States)

^h VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

ⁱ South Texas Veterans HCS   (United States)

^j UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^k LONDON HEALTH SCIENCES CENTRE   (Canada)

^l MONTREAL HEART INSTITUTE   (Canada)

^m SAINT LOUIS UNIVERSITY   (United States)

ⁿ FOOTHILLS HOSPITAL   (Canada)

^o UNIVERSITY OF MICHIGAN   (United States)

^p MCMASTER UNIVERSITY   (Canada)

^q UNIVERSITY AT BUFFALO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; EZETIMIBE PLUS SIMVASTATIN; ISOSORBIDE MONONITRATE; LISINOPRIL; LOSARTAN; METOPROLOL; SIMVASTATIN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIAC PATIENT; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 84864691622     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.05.018     Document Type: Article

References (30)

1. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516 (Pubitemid 46588415)
2. R.L. Frye, P. August, and M.M. Brooks A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
3. W.E. Boden Routine invasive versus selective invasive approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era J Am Coll Cardiol 41 2003 113S 122S (Pubitemid 36223355)
4. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators Lancet 354 1999 708 715
5. K.A. Fox, P. Poole-Wilson, and T.C. Clayton 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial Lancet 366 2005 914 920 (Pubitemid 41265665)
6. W.S. Weintraub Is an invasive interventional strategy of value in non-ST-elevation acute coronary syndromes? Nat Clin Pract Cardiovasc Med 5 2008 754 755
7. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887 (Pubitemid 32564900)
8. K.K. Teo, S.P. Sedlis, and W.E. Boden Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial J Am Coll Cardiol 54 2009 1303 1308
9. S. Kaul, and G.A. Diamond Current status and future trends in drug-eluting stents Am Heart Hosp J 5 2007 165 168
10. G.A. Diamond, and S. Kaul COURAGE under fire: on the management of stable coronary disease J Am Coll Cardiol 50 2007 1604 1609 (Pubitemid 47532335)
11. D.J. Kereiakes, P.S. Teirstein, and I.J. Sarembock The truth and consequences of the COURAGE trial J Am Coll Cardiol 50 2007 1598 1603 (Pubitemid 47542361)
12. D.J. Kereiakes Interpreting the COURAGE trial. PCI is no better than medical therapy for stable angina? Seeing is not believing Cleve Clin J Med 74 2007 637 638 40-2
13. D.J. Maron, J.A. Spertus, and G.B. Mancini Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Am J Cardiol 104 2009 1055 1062
14. R. Hachamovitch, D.S. Berman, and L.J. Shaw Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction Circulation 97 1998 535 543 (Pubitemid 28090682)
15. L.J. Shaw, R. Hachamovitch, and G.V. Heller Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study Group Am J Cardiol 86 2000 1 7 (Pubitemid 30365134)
16. R. Hachamovitch Risk assessment of patients with known or suspected CAD using stress myocardial perfusion SPECT. Part I: the ongoing evolution of clinical evidence Rev Cardiovasc Med 1 2000 91 102
17. R. Hachamovitch, S.W. Hayes, and J.D. Friedman Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2003 2900 2907
18. R. Hachamovitch, A. Rozanski, and S.W. Hayes Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol 13 2006 768 778 (Pubitemid 44913652)
19. A.K. Gehi, S. Ali, and B. Na Inducible ischemia and the risk of recurrent cardiovascular events in outpatients with stable coronary heart disease: the heart and soul study Arch Intern Med 168 2008 1423 1428 (Pubitemid 352013496)
20. L.J. Shaw, G.V. Heller, and P. Casperson Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424 Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology 13 2006 685 698 (Pubitemid 44375494)
21. L.J. Shaw, D.S. Berman, and D.J. Maron Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291 (Pubitemid 351365675)
22. http://www.asnc.org/imageuploads/ImagingGuidelineSPECTJune2010.pdf.
23. http://www.clinicaltrials.gov/ct2/show/NCT01471522?term= ISCHEMIA&rank=1.
24. J.H. O'Keefe Jr., T.M. Bateman, and R.W. Ligon Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease J Nucl Cardiol 5 1998 28 33 (Pubitemid 28084963)
25. D.S. Berman, A. Abidov, and X. Kang Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation J Nucl Cardiol 11 2004 414 423 (Pubitemid 39107079)
26. Updated imaging guidelines for nuclear cardiology procedures, part 1 J Nucl Cardiol 8 2001 G5 G58
27. D.S. Berman, X. Kang, and H. Gransar Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis J Nucl Cardiol 16 2009 45 53
28. R.G. Schwartz, T.A. Pearson, and V.G. Kalaria Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial J Am Coll Cardiol 42 2003 600 610 (Pubitemid 37000172)
29. J.J. Mahmarian, H.A. Dakik, and N.G. Filipchuk An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction Journal of the American College of Cardiology 48 2006 2458 2467 (Pubitemid 44881230)
30. W.S. Weintraub, J.A. Spertus, and P. Kolm Effect of PCI on quality of life in patients with stable coronary disease N Engl J Med 359 2008 677 687